Literature DB >> 7622179

Identification of a cytolytic protein in the coelomic fluid of Eisenia foetida earthworms.

M Bilej1, L Brys, A Beschin, R Lucas, E Vercauteren, R Hanusová, P De Baetselier.   

Abstract

Total coelomic fluid of earthworms Eisenia foetida (Oligochaeta, Annelida) is capable of lysing different mammalian tumor cell lines. This cytolytic activity is different from tumor necrosis factor (TNF)-mediated lysis and is not due to proteolysis. Total coelomic fluid was subjected to ion-exchange chromatography separation and a fraction with prominent cytolytic activity was used to elicit monoclonal antibodies that were screened for their capacity to neutralize the cytolytic effect of total coelomic fluid. One of the prepared neutralizing IgG antibodies was used for the immunoaffinity purification of a cytolytic factor from total coelomic fluid. SDS-PAGE and Western blot analyses revealed a protein band with an apparent molecular weight of 42 kDa. This cytolytic protein (termed CCF-1 or coelomic cytolytic factor 1) can be adsorbed on the surface of opsonized particles and may be involved in opsonizing and hemolytic effects of coelomic fluid.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622179     DOI: 10.1016/0165-2478(94)00248-p

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

Review 1.  Antimicrobial defense of the earthworm.

Authors:  M Bilej; P De Baetselier; A Beschin
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

2.  Lesion of leukocytes, erythrocytes, and mesothelial cells by the coelomic fluid of Eisenia foetida earthworms.

Authors:  P Rossmann; M Bilej; L Tucková; V Starý; O Kofronová
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.099

3.  Microbial environment affects innate immunity in two closely related earthworm species Eisenia andrei and Eisenia fetida.

Authors:  Jiří Dvořák; Veronika Mančíková; Václav Pižl; Dana Elhottová; Marcela Silerová; Radka Roubalová; František Skanta; Petra Procházková; Martin Bilej
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.